Amoxicillin 500 mg + Clavulanic Acid 125 mg (Tab)

Product Overview

YASCLAVIN-CV is an extended-spectrum antibacterial formulation containing Amoxicillin 500 mg and Clavulanate 125 mg. Amoxicillin binds penicillin-binding proteins (PBPs) to inhibit bacterial peptidoglycan cell wall synthesis, triggering cell lysis. Clavulanate acts as an irreversible beta-lactamase inhibitor, binding and inactivating bacterial resistance enzymes to protect amoxicillin from degradation and restore its broad antibacterial spectrum.
Designed to conquer tough or resistant infections, this reinforced antibiotic works as a team: amoxicillin destroys the protective outer wall of bacteria to kill them, while clavulanate acts as a shield to prevent bacteria from disabling the medicine.
Developed under stringent quality standards, YASCLAVIN-CV ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Resistant Bacterial Infections of the Respiratory, ENT, and Urinary Tracts.

Broad-spectrum antibacterial activity against resistant pathogens.
Clavulanic Acid inhibits β-lactamase enzymes, restoring Amoxicillin’s effectiveness.
Rapid symptom relief and bacterial eradication across multiple infection types.
Well-tolerated with excellent clinical success rates.

Each film-coated tablet contains:

Provides enhanced efficacy in infections unresponsive to Amoxicillin alone.
Ensures broad and reliable infection control across multiple body systems.
Minimizes antimicrobial resistance development through dual mechanism.
Trusted first-line therapy for bacterial infections in both outpatient and inpatient settings.

Part of YaselleZyntrix – Anti-Infectives & Critical Care Division
Defending health through science-driven infection control.